Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
This is a manufacturer of 3v krome cobalt chromium stent system, 3v paulo ptca balloon dilatation catheter & 3v extra aspiration catheter.
S3V Vascular Technologies Limited, is an unlisted public company incorporated on 09 August, 2011. It is classified as a public limited company and is located in , Karnataka. It's authorized share capital is INR 25.00 cr and the total paid-up capital is INR 19.18 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Badari Narayan Nagarada Gadde
Shareholder
|
00569510 | 14 years |
| Director | Narayan Kalindhi
Shareholder
|
03484025 | 14 years |
| Managing Director | Vijaya Gopal Nagaradagadde
Shareholder
|
03490341 | 14 years |
| Director | Narendra Kumar Srisrimal
Shareholder
|
01868425 | 5 years |
| Director | Venkateswara Gowtama Mannava
Shareholder
|
07628039 | 3 years |
| Whole-time Director | Nagarada Gadde Vishnu Shreyas
Shareholder
|
06949149 | 7 years |
| Director | Veeresham Ciddi
Shareholder
|
09630830 | 4 years |
| Director | Prithi Sureka Mummidi | 09632648 | 4 years |
| Nominee Director | Dip Kishore | 03554707 | 2 years |
| Director | Govindan Ramaswamy | 05148785 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
TECHNOLOGY DEVELOPMENT BOARD
No. of Loans: 2
Total Amount : 112.8 cr
Indian Overseas Bank
No. of Loans: 3
Total Amount : 68.2 cr
Read more
The incorporation date of S3V VASCULAR TECHNOLOGIES LIMITED is 09 August, 2011
The authorized share capital of S3V VASCULAR TECHNOLOGIES LIMITED is INR ₹ 25.0 Cr.
The paid-up capital of S3V VASCULAR TECHNOLOGIES LIMITED is INR ₹ 19.2 Cr.
The registered address of S3V VASCULAR TECHNOLOGIES LIMITED is Plot No. 65/D4, Hootagalli Industrial Area Hootagalli, Mysore, Mysuru, Karnataka, India, 570018 - 570018
The CIN number of S3V VASCULAR TECHNOLOGIES LIMITED is U33112KA2011PLC059915.